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Abstract
Background Heterocyclic amines (HCA) are positively
associated with prostate cancer risk in animal models.
Because of mostly inconsistent results of epidemiological
studies, we examined the association between intake of
HCA and prostate cancer risk.
Methods In the EPIC-Heidelberg cohort, detailed
information on diet, anthropometry, and lifestyle was
assessed between 1994 and 1998. Dietary HCA intake was
estimated using information on meat consumption, cook-
ing methods, and preferred degree of browning. During
104,195 person-years of follow-up, 337 incident cases
of prostate cancer (123 advanced cases) were identified
among 9,578 men with valid dietary information.
Multivariate Cox proportional hazards regression was used
to examine the association between intake of 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,
8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-
amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline (DiMeIQx)
and prostate cancer.
Results Men in the highest quartiles of PhIP, MeIQx, and
DiMeIQx intake, respectively, had no increased risk of
prostate cancer compared with men in the lowest quartiles
(HR = 0.89, 95% CI 0.66–1.22 [PhIP]; 1.06, 0.77–1.45
[MeIQx]; 0.98, 0.72–1.34 [DiMeIQx]). There were no
associations between HCA intake and advanced prostate
cancer or between high consumption of strongly browned
meat and prostate cancer.
Discussion Our data do not support the hypothesis that
HCA intake as consumed in a regular diet is a risk factor
for prostate cancer.
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Introduction
In vitro and in vivo experiments indicate that heterocyclic
aromatic amines (HCAs) are some of the most potent
mutagens [1]. These compounds are formed from amino
acids, creatin(in)e, and sugar during cooking of fish and/or
meat at high temperatures. The amount depends on cooking
temperature, cooking time, type of meat, and cooking
method. The most mass-abundant HCAs detected in
cooked meat are 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo [4,5-
f]quinoxaline (MeIQx), and 2-amino-3,4,8-dimethylimi-
dazo[4,5-f]quinoxaline (DiMeIQx).
In experimental studies, N-hydroxy derivates of PhIP
and of MeIQx were shown to be potential carcinogens for
the prostate [2]. In a rat model, Nakai et al. [3] have shown
that an increased proliferation and cell death in response
to PhIP, which indicates that in addition to PhIP acting
as an ‘‘initiator’’ of cancer, PhIP might also act like a
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lobe-specific tumor ‘‘promoter.’’ In humans, a number of
epidemiological studies have shown that high intake of
well done meat and high exposure to meat carcinogens,
like HCAs, may increase the risk of a number of common
cancers such as breast and colorectal cancer [4–6]. For
prostate cancer, some studies have evaluated the associa-
tion between consumption of different types of meat and
prostate cancer risk. Some of them showed a positive
association between meat consumption and prostate cancer,
especially for well done and red meat [7–10], but others
reported no association [11–13]. The few studies with
focus on HCA intake revealed inconsistent results; two
studies reported no association [8, 10], whereas one study
indicated an increasing risk for the intake of PhIP [9] and
another one an increased risk for MeIQx and DiMeIQx [7].
Because of mostly inconsistent results, it was the aim of
this study to examine the association between intake of
meat prepared with different degrees of browning and HCA
intake with the risk of prostate cancer in the EPIC-
Heidelberg cohort study.
Subjects and methods
Population
The EPIC-Heidelberg cohort is part of the European Pro-
spective Investigation into Cancer and Nutrition, a pro-
spective cohort study conducted in ten countries. From
1994 to 1998, a total of 11,928 men aged 40–65 years and
13,612 women aged 35–65 years were recruited from the
general population of Heidelberg and surrounding com-
munities. Information on diet, lifestyle, and health was
obtained at baseline by means of questionnaires and face-
to-face interviews [14]. The cohort is followed up by
mailed questionnaires in intervals of about 3 years to
assess information on health status, diet, and lifestyle [15].
Diet was assessed by using a validated food-frequency
questionnaire (FFQ) [16].
During the second follow-up of the cohort (2002–2004),
11,605 men have been contacted; of these, 9,864 partici-
pants completed a 158-item FFQ. This FFQ included
detailed questions on meat preparation methods and pre-
ferred degree of browning, i.e., the outside appearance of
the meat, using four pictures (lightly/moderately/strongly/
extremely browned) as reference and assistance. Mean
daily dietary intake of HCAs from meat was calculated by
using published data of the HCA content of different types
of meat in combination with information on degree of
browning, cooking methods, and the amount of meat intake
[17].
Identification of incident prostate cancer cases was
based on self-reported primary prostate cancer during
follow-up or on death certificates that were coded for
prostate cancer as the underlying cause of death. All cases
were verified by medical records, death certificates, or
both. Information on stage and grade of prostate cancer was
extracted by the study physician from pathology reports,
including tumor nodal metastasis (TNM) stage and Gleason
histologic grade. Advanced prostate cancer was defined as
prostate cancer with a Gleason sum score equal or higher
than seven, a TNM staging score of T3/T4, N1-N3, or M1,
or prostate cancer as the underlying cause of death.
Although prone to detection bias, stage T1a cases were
included in the analysis because their low number (seven
T1a cases [2.8% of all cases]) was unlikely to affect the
results.
After excluding men with prevalent cancer or with
missing information on food preparation methods and
preferred degree of browning, our study population com-
prises a total of 9,578 men. Among these, 337 incident
cases of prostate cancer (including 123 advanced cases,
which included 22 fatal cases) have been diagnosed until
31 July 2009.
All participants gave written informed consent. EPIC-
Heidelberg has been approved by the ethical committee of
Heidelberg University Medical School.
Statistical analyses
The association of total and advanced prostate cancer with
intake of the three most abundant HCAs (PhIP, MeIQx, and
DiMeIQx) and meat consumption by degree of browning
was analyzed using Cox proportional hazards regression,
modeling the intake variables as a categorical variable
based on quartiles of intake in the cohort, with the first
quartile being the reference category. Age was used as the
primary time variable in the Cox models. Time at entry was
age at recruitment, and time of exit was the age at which
participants were diagnosed with cancer, died, were lost to
follow-up, or were censored at the end of the follow-up
period, whichever came first. The analyses were stratified
by age at recruitment in 1-year categories. In multivariate
regression models, we adjusted for smoking status at
baseline (never, former, or current), family history of
prostate cancer (yes/no), participation in prostate-specific
antigen (PSA)-screening tests (yes/no), and intake of dairy
products (entered as quartiles). Additional adjustment for
other possible confounders (tomato products, body mass
index, total energy intake, alcohol intake, and vigorous
physical activity) had no statistically significant effects on
the risk of prostate cancer (p \ 0.20).
The results are given as hazard ratios (HR) and 95%
confidence intervals (CI). We also examined whether the
observed associations of HCA intake and prostate cancer
changed if we examined the three HCAs in a combined
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model additionally controlled for red and processed meat
(entered as quartiles).
To test for linear trend across categories, we used the
continuous variables. All tests were two-sided; p values
\ 0.05 were considered to be statistically significant. All
statistical analyses were performed with SAS software
(version 9.1; SAS Institute, Cary, NC).
Results
Baseline characteristics of the study participants are shown
in Table 1. Compared with men in the lowest quartile of
total HCA intake, men in the highest quartile tended to
have a higher BMI and a higher total energy intake, to
consume more alcohol, tomato products, a lower con-
sumption of dairy products, and were more likely to be
current smokers (Table 1). There was no significant asso-
ciation between HCA intake and risk of prostate cancer;
men in the highest quartiles of PhIP, MeIQx, and DiMeIQx
intake, respectively, did not have an increased risk of
prostate cancer compared with men in the lowest quartiles
(HR = 0.89, 95% CI 0.66–1.22 [PhIP]; 1.06, 0.77–1.45
[MeIQx]; 0.98, 0.72–1.34 [DiMeIQx]; Table 2). No sta-
tistically significant associations were observed when we
considered advanced cases (Table 2). In addition, we did
not see clear relationships with prostate cancer stratified by
stage or grade (data not shown).
There were also no consistent associations between
consumption of meat by degree of browning and total or
advanced prostate cancer incidence; men in the second and
third quartile of strongly and extremely browned meat had
an increased risk of prostate cancer, but there was no sta-
tistically significant association when comparing men with
the highest consumption of strongly browned meat to those
with the lowest intake (Table 2).
As already seen in the entire EPIC cohort [18], we
observed no statistically significant association between
red or processed meat intake and prostate cancer risk in the
EPIC-Heidelberg cohort (data not shown).
Discussion
In this prospective cohort study, the estimated dietary
intake of HCAs was not associated with the risk of prostate
cancer. The consumption of strongly/extremely browned
meat was also not consistently related to prostate cancer
incidence.
Our result of no association between HCA intake and
prostate cancer incidence is comparable with some [8, 10]
but not other [7, 9] previous studies. A case–control study
with 317 cases in New Zealand [8] did not find an
association between HCA intake and prostate cancer risk.
Cross et al. [9] observed in their cohort study with 29,361
men and 868 incident cases of prostate cancer no associ-
ation between intake of different types of meat or the
intake of MeIQx and DiMeIQx, respectively, and risk of
prostate cancer. However, an increased risk of prostate
cancer was observed in subjects with high intake of PhIP
[all cases: relative risk (RR) 1.22, 95% CI (1.01–1.48);
incident cases: 1.28, 95% CI (1.01–1.61), top vs bottom
quintile] and very well done meat [all cases: RR 1.42, 95%
CI (1.05–1.92); incident cases: 1.69, 95% CI (1.19–2.40)].
Within the Agricultural Health Study, Koutros et al. [6]
observed a positive association of well and very well done
meat consumption with risk of prostate cancer. For MeIQx
and DiMeIQx intake, they observed a non-significantly
increased risk of prostate cancer. In a large prospective
cohort study in the United States, a high intake of red,
processed as well as grilled/barbecued meat was associated
with elevated risks of total and advanced prostate cancer,
but they did not observe statistically significant associa-
tions between HCA intake and prostate cancer [10].
The estimation of daily HCA intake is mostly based on
data derived from FFQs that are commonly used in epi-
demiological studies. However, HCA intake estimations
suffer from imprecision. Assessing a person’s dietary
intake by means of a FFQ is prone to recall bias, such that
study participants may over- or underestimate their dietary
intake leading to misclassification with respect to dietary
intake. Second, the use of limited data on the HCA content
in differently prepared meats for the computation of HCA
intake [17] is another major shortcoming of this approach
to quantify intake. HCA intake was lower in our cohort
than in previous studies, in particular US studies, and food
sources contributing most to HCA intake also differs
between studies [17]. This may partly explain differences
in results between studies. However, we have previously
shown in our cohort a positive association between HCA
intake, in particular PhIP, and the risk of colorectal ade-
nomas [5], which is in line with findings from other studies.
HCA formation is a function of duration and temperature
of the cooking process as well as of the cooking method
itself [19], such that the content of HCAs depends on the
degree of browning as well as on the degree of doneness of
the meat. For example, cooking short time by high tem-
perature and long time by lower temperature can result in
the same degree of browning but not in the same degree of
doneness and, thus, in different amounts of HCAs. It has
been shown that this effect may lead to an underestimation
of exposure [19]. Nevertheless, recent investigations have
shown that validated FFQs can result in reasonable esti-
mations of levels of HCA intake [20]. Kobayashi et al. [21]
compared the intake of some HCAs and total HCA intake
estimated from a FFQ with the PhIP level in hair samples.
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Under adjustment for melanin content, they observed sta-
tistically significant correlations for PhIP and total HCA
intake by FFQ with the respective levels in hair (r = 0.47
and r = 0.51, respectively) [22].
The results of our and also some other studies showing
no association between intake of HCA and prostate cancer
risk could possibly be explained by the fact that food, e.g.,
processed meat, also contains other compounds than HCAs
that can act as mutagens/carcinogens. Nitrite and nitrate,
polycyclic aromatic hydrocarbons, and heme iron are such
compounds [10, 23]. In this case, however, one might
expect a positive association between meat, meat sub-
groups (e.g., red or processed meat), or strongly browned
meat as reported by Sinha et al. [10]. However, we did not
observe a consistently increased risk of prostate cancer
with high consumption of strongly/extremely browned
meat. A second factor that needs to be taken into account is
the role of genetic polymorphisms that affect the metabo-
lism of HCAs and, thus, their potential carcinogenic effect
[24]. Thirdly, it is difficult to consider all factors that can
affect and modulate the risk of prostate cancer; bias arising
from unrecognized confounding remains a potential weak
point in any observational study design especially because
there are only few well-recognized prostate cancer risk
factors. Lastly, the number of cases in our study is smaller
than in other studies [9, 10, 24] and the power was, thus,
lower to observe a small to moderate but statistically sig-
nificant association.
Table 1 Baseline characteristics of men of the EPIC-Heidelberg cohort over quartiles of total HCA intake
Quartiles of total HCA intake [ng/day]
\26.09 26.09 to \61.45 61.45 to \148.14 C148.14 p valuea
Total (n) 2,394 2,395 2,394 2,395 0.02
Cases (n, %) 99 (4.1) 97 (4.1) 70 (2.9) 71 (3.0) 0.01
Advanced (n, %) 36 (1.5) 37 (1.5) 31 (1.3) 19 (0.8) 0.02
Age (years)b 52.9 ± 7.1 52.5 ± 7.1 51.4 ± 6.9 50.8 ± 7.0 \0.01
Body mass index (kg/m2)b 26.3 ± 3.4 26.7 ± 3.4 27.1 ± 3.7 27.4 ± 3.7 \0.01
HCA intake (ng/d)
PhIPc 6.7 (0.0–24.1) 22.6 (0.5–59.5) 59.9 (1.0–143.9) 197.2 (32.1–5,967) \0.01
MeIQxc 4.8 (0.0–23.0) 14.6 (0.0–44.9) 28.5 (0.4–101.5) 69.5 (1.7–3,097) \0.01
DiMeIQxc 0.7 (0.0–9.1) 1.9 (0.0–14.6) 3.3 (0.0–26.3) 5.1 (0.0–271.0) \0.01
Energy intake (kcal/d)b 1,999 ± 632 2,130 ± 623 2,291 ± 830 2,407 ± 853 \0.01
Dairy products (g/d)b 253.0 ± 270.0 228.0 ± 224.0 233.7 ± 231.7 232.9 ± 245.8 \0.01
Tomatoes, tomato products (g/d)b (g/d)* 22.4 ± 15.2 22.8 ± 13.8 24.4 ± 15.5 25.9 ± 21.5 \0.01
Red meat (g/d)b 22.6 ± 20.1 36.1 ± 23.2 47.4 ± 31.2 58.7 ± 48.0 \0.01
Processed meat (g/d)b 45.1 ± 35 61.2 ± 39.5 72.6 ± 49.5 78.4 ± 57.6 \0.01
White meat (g/d)b 8.5 ± 9.7 13.5 ± 13.7 14.9 ± 14.3 18.8 ± 20.3 \0.01
Alcohol (g/d)b 22.0 ± 26.3 25.9 ± 26.0 26.4 ± 26.6 28.0 ± 28.0 \0.01
Vigorous physical activity (%)d
None 34.3 34.3 34 31.5 0.08
B2 h/wk 38.9 37.5 37.2 37.8 0.61
[2 h/wk 26.9 28.1 28.8 30.7 \0.01
Smoking status (%)
Never 36.1 32 28.7 29 \0.01
Former 48 47.5 46.8 45.6 0.09
Current 15.9 20.5 24.6 25.3 \0.01
Family history of prostate cancer (%) 4.7 4.1 4.1 3.9 0.2
Participation in PSA screening (%)e 63.2 62.3 57.4 58.5 0.02
a Jonckheere–Terpstra Test
b Mean ± SD
c Median and interquartile range by quintile of total HCA intake
d Unknown/missing information on physical activity for 101/91 participants
e 758 participants with no information about PSA screening
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In conclusion, our data do not support the hypothesis
that HCA intake as consumed in a regular diet is a risk
factor for prostate cancer.
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